UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth 
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
WATERBURY, Conn., March 06, 2018 -- Northeast Scientific Inc. (NES) has released 5-year results proving that the use of their reprocessed medical devices is safe, effective and smart. NES has successfully supplied 250,000 reprocessed VNUS ClosureFast RF Ablation Catheters with no adverse events and exceptional physician savings.
Proven Performance
- Less than 0.25% (less than 1 in 400) of NES reprocessed devices are returned for performance failure.
- NES inspects every single device, not just a sampling like most OEMs.
- Any user who is not happy with the device for any reason is given full credit.
Excellent Safety Record
NES has supplied the reprocessed device for more than 5 years with NO ADVERSE EVENTS.
Search for the keyword “closurefast” on the FDA MAUDE database to see all adverse events involving the ClosureFast catheter.
Smart Doctors
Search online for doctors who use the NES reprocessed catheter and consult with other physicians: Reprocessing makes strong financial sense for the practice. Some save more than $100,000 each year on devices alone.
Simple math
Doctors pay on average 35% less for the reprocessed VNUS ClosureFast Catheter, and the savings compound with increased use of NES devices.
35% savings with a device that is proven safe and effective by doctors across the country.
Visit www.smarthealth-care.com to learn more about Northeast Scientific Inc. Come see the operation in Waterbury, CT. Call anytime with any questions 203.756.2111.
Watch a video about NES here https://www.smarthealth-care.com/about-us/
See what else NES does here – www.worldpace.org
About Northeast Scientific
Northeast Scientific, Inc. (NES), in Waterbury, Connecticut, is registered with the U.S. Food and Drug Administration as both a reprocessor of single-use medical devices and a manufacturer. Founded in 2005, NES received its first 510(k) clearance in 2007, has added new products to its reprocessing suite and is developing multiple 510ks in the vascular space. NES is ISO 13485 2016 Certified.
Northeast Scientific Inc. Media Contact
Scott Allmendinger 203.756.2111
